Simultaneous registration of cerebral tissue oxygenation parameters obtained by near infrared spectroscopy (NIRS), intracranial blood flow velocity (CBFV) measured by transcranial Doppler sonography (TCD) and basic cardiovascular parameters was carried out during a passive 80° head-up tilt table test in 15 patients with a history of orthostatic syncope and 20 control subjects. In normals, the cardiovascular parameters showed a specific course after changing to a vertical position: the heart rate increased, the mean arterial blood pressure remained unchanged, and the CBFV decreased. The NIRS measurements showed an increase in deoxyhemoglobin (HHb) and a decline in oxyhemoglobin (O2Hb) and the regional oxygen saturation (RSAT). Patients had a significantly more prominent decline in arterial blood pressure (p < 0.001), CBFV (p < 0.001) and RSAT (p = 0.04). Five patients experienced symptoms of (pre)syncope during the experiment, which were associated with a further sudden and marked (>10%) drop of O2Hb. The results indicate that the combination of TCD and NIRS increases the understanding of hemodynamic and metabolic changes during orthostatic stress, which may lead to individually suited therapeutic procedures.

Keywords:
Near infrared spectroscopy, Transcranial Doppler sonography, Cerebral blood flow, Cerebral blood oxygenation, Orthostasis, Neurocardiogenic syncope
1.
Levine BD, Giller CA, Lane LD, Buckey JC, Blomqvist CG: Cerebral versus systemic hemodynamics during graded orthostatic stress in humans. Circulation 1994;90:298–306.
2.
van Lieshout JJ, Wieling W, Karemaker JM: Neural circulatory control in vasovagal syncope. Pace 1997;20:753–763.
3.
Aminoff MJ: Postural hypotension; in Aminoff MJ (ed): Neurology and General Medicine. The Neurological Aspects of Medical Disorders. New York, Churchill Livingstone, 1995, pp 123–143.
4.
Daffertshofer M, Hennerici M: Cerebrovascular regulation and vasoneuronal coupling. J Clin Ultrasound 1995;23:125–138.
5.
Ladwig S, Ries S, Henning O, Valikovics A, Daffertshofer M, Pohlmann-Eden B: Combined electroencephalography and measurements of transcranial blood flow velocity during Schellong testing – A new approach to assess syncope of unknown origin? Clin Auton Res 1997;7:1–5.
6.
Grubb BP, Samoil D, Kosinski D, Wolfe D, Brewster P, Elliott L, Hahn H: Cerebral syncope: Loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. Pace 1998;21:652–658.
7.
Lindgaard KF, Lundar T, Wiberg J: Variations in middle cerebral artery blood flow investigated with noninvasive transcranial blood velocity measurements. Stroke 1987;18:1025–1030.
8.
Jobsis FF: Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977;198:1264–1267.
9.
Cope M, Delpy DT, Reynolds EO, Wray S, Wyatt J, van der Zee P: Methods of quantitating cerebral near infrared spectroscopy data. Adv Exp Med Biol 1988;222:183–189.
10.
McCormick PW, Stewart M, Goetting MG: Regional cerebrovascular oxygen saturation measured by optical spectroscopy in humans. Stroke 1991;22:596–602.
11.
Villringer A, Planck J, Hock C, Schleinkofer L, Dirnagl U: Near infrared spectroscopy (NIRS): A new tool to study hemodynamic changes during activation of brain function in human adults. Neurosci Lett 1993;154:101–104.
12.
Villringer A, Planck A, Stodieck S, Boetzel K, Schleinkofer L, Dirnagl U: Noninvasive assessment of cerebral hemodynamics and tissue oxygenation during activation of brain cell function in human adults using near infrared spectroscopy; in Vaupel P (ed): Oxygen Transport to Tissue. New York, Plenum press, 1994, pp 559–565.
13.
Duncan A, Meek JH, Clemence M, Elwell CE, Fallon P, Tyszczuk L, Cope M, Delpy DT: Measurement of cranial optical path length as a function of age using phase resolved near infrared spectroscopy. Pediatr Res 1996;39:889–894.
14.
Van de Zee P, Arridge SR, Cope M: The effect of optode positioning on optical pathlength in near infrared spectroscopy of brain. Adv Exp Med Biol 1990;227:79–84.
15.
Hennerici M, Nauerburg-Heusler D (eds): Vascular Diagnosis with Ultrasound. Stuttgart, Thieme, 1995.
16.
Firbank M, Okada E, Delpy DT: A theoretical study of the signal contribution of regions of the adult head to near-infrared spectroscopy studies of visual evoked responses. Neuroimage 1998;8:69–78.
17.
Töyry JP, Kuikka JT, Länsimies EA: Regional cerebral perfusion in cardiovascular reflex syncope. Eur J Nucl Med 1997;24:215–218.
18.
Gomez CR, Gomez SM, Hall IS: The elusive transtemporal window: A technical and demographic study. J Cardiovasc Technol 1989;8:171–172.
19.
Grubb BP, Gerard G, Roush K, Temesy-Armos P, Montford P, Elliot T, Hahn H, Brewster P: Cerebral vasoconstriction due to head upright tilt-induced vasovagal syncope. Circulation 1991;84:1157–1164.
20.
Daffertshofer M, Diehl RR, Ziems GU, Hennerici M: Orthostatic changes of cerebral blood flow velocity in patients with autonomic dysfunction. J Neurol Sci 1991;104:32–38.
21.
Colier WN, Binkhorst RA, Hopman MT, Oeseburg B: Cerebral and circulatory haemodynamics before vasovagal syncope induced by orthostatic stress. Clin Physiol 1997;17:83–94.
22.
Madsen P, Lyck F, Pedersen M, Olesen HL, Bay Nielsen H, Secher NH: Brain and muscle oxygen saturation during head-up-tilt-induced central hypovolaemia in humans. Clin Physiol 1995;15:523–533.
23.
Madsen P, Pott F, Olsen SB, Bay Nielsen H, Burcev I, Secher NH: Near-infrared spectrophotometry determined brain oxygenation during fainting. Acta Physiol Scand 1998;162:501–507.
24.
Glaister DH, Miller NL: Cerebral tissue oxygen status and psychomotor performance during lower body negative pressure (LBNP). Aviat Space Environ Med 1990;61:99–105.
25.
Rodriguez-Nunez A, Couceiro J, Alonso C, Eiris J, Fuster M, Sanchez L, Martinon JM: Cerebral oxygenation in children with syncope during head-upright tilt test. Pediatr Cardiol 1997;18:406–409.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.